What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His main research concerns Biochemistry, Amyloid precursor protein, Alzheimer's disease, Presenilin and Disease.
The concepts of his Biochemistry study are interwoven with issues in In vivo and Cell biology.
His Amyloid precursor protein study integrates concerns from other disciplines, such as Endosome and Amyloid.
His Alzheimer's disease study deals with the bigger picture of Internal medicine.
His studies in Internal medicine integrate themes in fields like Endocrinology and Traumatic brain injury.
The study incorporates disciplines such as Molecular biology, Dementia, Genetically modified mouse and Gene in addition to Presenilin.
His most cited work include:
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo (1356 citations)
- ENDOPROTEOLYSIS OF PRESENILIN 1 AND ACCUMULATION OF PROCESSED DERIVATIVES IN VIVO (950 citations)
- Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing (587 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Alzheimer's disease, Amyloid precursor protein, Internal medicine, Disease and Biochemistry.
His research integrates issues of Degenerative disease, Neuroscience, Immunology and Amyloidosis in his study of Alzheimer's disease.
He interconnects Cell biology and Amyloid in the investigation of issues within Amyloid precursor protein.
His biological study spans a wide range of topics, including Mutant and Presenilin.
His Internal medicine research includes elements of Endocrinology and Oncology.
His work carried out in the field of Disease brings together such families of science as Pathogenesis and Bioinformatics.
He most often published in these fields:
- Alzheimer's disease (25.90%)
- Amyloid precursor protein (26.23%)
- Internal medicine (25.25%)
What were the highlights of his more recent work (between 2013-2021)?
- Dementia (18.03%)
- Disease (21.97%)
- Neuroscience (16.39%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Dementia, Disease, Neuroscience, Traumatic brain injury and Alzheimer's disease.
His Dementia research is multidisciplinary, relying on both Gerontology and Risk factor.
His study looks at the intersection of Disease and topics like Computational biology with Human virome.
His Traumatic brain injury research integrates issues from Cognition, Tauopathy and Pathology.
Alzheimer's disease is a primary field of his research addressed under Internal medicine.
His Internal medicine research is multidisciplinary, incorporating perspectives in Signal transduction and Gene.
Between 2013 and 2021, his most popular works were:
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums (345 citations)
- Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. (281 citations)
- Directed Differentiation of Human Pluripotent Stem Cells to Microglia. (138 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Sam Gandy spends much of his time researching Dementia, Alzheimer's disease, Pathology, Neuroscience and Tauopathy.
His study on Dementia is covered under Disease.
Sam Gandy performs multidisciplinary study on Alzheimer's disease and Luminescent Agents in his works.
His Pathology study combines topics from a wide range of disciplines, such as Positron emission tomography, Radiology and Neuropsychological assessment.
His studies deal with areas such as Phenotype, Genetically modified mouse and Point mutation as well as Neuroscience.
In his study, which falls under the umbrella issue of Tauopathy, Brain damage, Pediatrics, Transgene and Neuroprotection is strongly linked to Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
